Published Erratum
doi: 10.2147/COPD.S130231.
eCollection 2017.
Erratum: Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting [Corrigendum]
- PMID: 28138230
- PMCID: PMC5237589
- DOI: 10.2147/COPD.S130231
Item in Clipboard
Published Erratum
Erratum: Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting [Corrigendum]
Int J Chron Obstruct Pulmon Dis.
.
Abstract
[This corrects the article on p. 2749 in vol. 11, PMID: 27853362.].
Erratum for
-
Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting.Int J Chron Obstruct Pulmon Dis. 2016 Nov 4;11:2749-2755. doi: 10.2147/COPD.S114554. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27853362 Free PMC article.
Similar articles
-
Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting.Int J Chron Obstruct Pulmon Dis. 2016 Nov 4;11:2749-2755. doi: 10.2147/COPD.S114554. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27853362 Free PMC article.
-
Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.J Intern Med. 2013 Jun;273(6):584-94. doi: 10.1111/joim.12067. Epub 2013 Apr 1. J Intern Med. 2013. PMID: 23495860
-
Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.Ther Adv Respir Dis. 2009 Aug;3(4):1-11. doi: 10.1177/1753465809344870. Epub 2009 Sep 4. Ther Adv Respir Dis. 2009. PMID: 19734176 Clinical Trial.
-
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.Pulm Pharmacol Ther. 2015 Feb;30:44-50. doi: 10.1016/j.pupt.2014.10.006. Epub 2014 Nov 6. Pulm Pharmacol Ther. 2015. PMID: 25445928 Review.
-
Canadian economic evaluation of budesonide-formoterol as maintenance and reliever treatment in patients with moderate to severe asthma.Can Respir J. 2007 Jul-Aug;14(5):269-75. doi: 10.1155/2007/560819. Can Respir J. 2007. PMID: 17703241 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
